SRC
LLY icon

Sage Rhino Capital’s Eli Lilly LLY Stock Holding History

Sage Rhino Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84M Buy
1,997
+1
+0.1% +$1.01K 0.34% 63
2025
Q4 		$2.15M Sell
1,996
-149
-7% -$142K 0.4% 53
2025
Q3 		$1.64M Sell
2,145
-6
-0.3% -$4.46K 0.32% 65
2025
Q2 		$1.68M Buy
2,151
+12
+0.6% +$9.32K 0.35% 59
2025
Q1 		$1.77M Buy
2,139
+10
+0.5% +$8.32K 0.41% 55
2024
Q4 		$1.64M Sell
2,129
-21
-1% -$17.4K 0.36% 57
2024
Q3 		$1.9M Buy
2,150
+7
+0.3% +$6.29K 0.42% 52
2024
Q2 		$1.94M Buy
2,143
+24
+1% +$19.2K 0.46% 51
2024
Q1 		$1.65M Buy
2,119
+16
+0.8% +$11.4K 0.39% 56
2023
Q4 		$1.23M Sell
2,103
-30
-1% -$17.5K 0.31% 64
2023
Q3 		$1.15M Hold
2,133
– – 0.32% 65
2023
Q2 		$1M Sell
2,133
-19
-0.9% -$7.97K 0.28% 73
2023
Q1 		$739K Buy
2,152
+38
+2% +$12.8K 0.22% 90
2022
Q4 		$773K Sell
2,114
-19
-0.9% -$6.74K 0.25% 80
2022
Q3 		$690K Sell
2,133
-17
-0.8% -$5.39K 0.28% 63
2022
Q2 		$697K Buy
2,150
+10
+0.5% +$3K 0.27% 66
2022
Q1 		$613K Buy
2,140
+2
+0.1% +$515 0.19% 101
2021
Q4 		$591K Sell
2,138
-12
-0.6% -$3.04K 0.17% 108
2021
Q3 		$497K Buy
2,150
+63
+3% +$15.5K 0.15% 107
2021
Q2 		$479K Buy
2,087
+42
+2% +$8.44K 0.14% 111
2021
Q1 		$382K Buy
2,045
+29
+1% +$5.67K 0.13% 120
2020
Q4 		$340K Buy
2,016
+46
+2% +$6.87K 0.13% 116
2020
Q3 		$292K Sell
1,970
-75
-4% -$11.6K 0.14% 117
2020
Q2 		$336K Buy
2,045
+118
+6% +$18.1K 0.18% 103
2020
Q1 		$267K Buy
1,927
+23
+1% +$3.16K 0.19% 97
2019
Q4 		$263K Sell
1,904
-583
-23% -$67.6K 0.15% 119
2019
Q3 		$278K Sell
2,487
-79
-3% -$8.79K 0.17% 109
2019
Q2 		$284K Sell
2,566
-144
-5% -$17K 0.18% 104
2019
Q1 		$352K Buy
+2,710
New +$330K 0.23% 89

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sage Rhino Capital's LLY Position: Q1 2026 in Review

Sage Rhino Capital increased its Eli Lilly (LLY) stake by 0.05% in Q1 2026, buying an estimated $1.01K and bringing the position to 1,997 shares worth $1.84M. The position accounts for 0.34% of the portfolio, ranked #63.

Sage Rhino Capital first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.15M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sage Rhino Capital held 1,997 shares of Eli Lilly worth $1.84M as of Q1 2026.
  • Sage Rhino Capital bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.34% of Sage Rhino Capital's portfolio in Q1 2026, its #63 holding.
  • Sage Rhino Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Sage Rhino Capital's Eli Lilly position peaked at $2.15M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sage Rhino Capital's 13F filing for Q1 2026, filed 28 Apr 2026.